WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 17.46 HKD 0.46%
Market Cap: 72.5B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

Intrinsic Value

The intrinsic value of one WuXi Biologics (Cayman) Inc stock under the Base Case scenario is 32.48 HKD. Compared to the current market price of 17.46 HKD, WuXi Biologics (Cayman) Inc is Undervalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
32.48 HKD
Undervaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
WuXi Biologics (Cayman) Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
WuXi Biologics (Cayman) Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for WuXi Biologics (Cayman) Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about WuXi Biologics (Cayman) Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

17.46 HKD
+0.46%
+0.46%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

WuXi Biologics (Cayman) Inc
CN
Life Sciences Tools & Services
Market Cap
72.5B HKD
IPO
Jun 13, 2017
Employees
7 686
China
Market Cap
72.5B HKD
Industry
Life Sciences Tools & Services
IPO
Jun 13, 2017
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about WuXi Biologics (Cayman) Inc

Provide an overview of the primary business activities
of WuXi Biologics (Cayman) Inc.

What unique competitive advantages
does WuXi Biologics (Cayman) Inc hold over its rivals?

What risks and challenges
does WuXi Biologics (Cayman) Inc face in the near future?

Summarize the latest earnings call
of WuXi Biologics (Cayman) Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for WuXi Biologics (Cayman) Inc.

Provide P/S
for WuXi Biologics (Cayman) Inc.

Provide P/E
for WuXi Biologics (Cayman) Inc.

Provide P/OCF
for WuXi Biologics (Cayman) Inc.

Provide P/FCFE
for WuXi Biologics (Cayman) Inc.

Provide P/B
for WuXi Biologics (Cayman) Inc.

Provide EV/S
for WuXi Biologics (Cayman) Inc.

Provide EV/GP
for WuXi Biologics (Cayman) Inc.

Provide EV/EBITDA
for WuXi Biologics (Cayman) Inc.

Provide EV/EBIT
for WuXi Biologics (Cayman) Inc.

Provide EV/OCF
for WuXi Biologics (Cayman) Inc.

Provide EV/FCFF
for WuXi Biologics (Cayman) Inc.

Provide EV/IC
for WuXi Biologics (Cayman) Inc.

Show me price targets
for WuXi Biologics (Cayman) Inc made by professional analysts.

What are the Revenue projections
for WuXi Biologics (Cayman) Inc?

How accurate were the past Revenue estimates
for WuXi Biologics (Cayman) Inc?

What are the Net Income projections
for WuXi Biologics (Cayman) Inc?

How accurate were the past Net Income estimates
for WuXi Biologics (Cayman) Inc?

What are the EPS projections
for WuXi Biologics (Cayman) Inc?

How accurate were the past EPS estimates
for WuXi Biologics (Cayman) Inc?

What are the EBIT projections
for WuXi Biologics (Cayman) Inc?

How accurate were the past EBIT estimates
for WuXi Biologics (Cayman) Inc?

Compare the revenue forecasts
for WuXi Biologics (Cayman) Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of WuXi Biologics (Cayman) Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of WuXi Biologics (Cayman) Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of WuXi Biologics (Cayman) Inc compared to its peers.

Compare the P/E ratios
of WuXi Biologics (Cayman) Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing WuXi Biologics (Cayman) Inc with its peers.

Analyze the financial leverage
of WuXi Biologics (Cayman) Inc compared to its main competitors.

Show all profitability ratios
for WuXi Biologics (Cayman) Inc.

Provide ROE
for WuXi Biologics (Cayman) Inc.

Provide ROA
for WuXi Biologics (Cayman) Inc.

Provide ROIC
for WuXi Biologics (Cayman) Inc.

Provide ROCE
for WuXi Biologics (Cayman) Inc.

Provide Gross Margin
for WuXi Biologics (Cayman) Inc.

Provide Operating Margin
for WuXi Biologics (Cayman) Inc.

Provide Net Margin
for WuXi Biologics (Cayman) Inc.

Provide FCF Margin
for WuXi Biologics (Cayman) Inc.

Show all solvency ratios
for WuXi Biologics (Cayman) Inc.

Provide D/E Ratio
for WuXi Biologics (Cayman) Inc.

Provide D/A Ratio
for WuXi Biologics (Cayman) Inc.

Provide Interest Coverage Ratio
for WuXi Biologics (Cayman) Inc.

Provide Altman Z-Score Ratio
for WuXi Biologics (Cayman) Inc.

Provide Quick Ratio
for WuXi Biologics (Cayman) Inc.

Provide Current Ratio
for WuXi Biologics (Cayman) Inc.

Provide Cash Ratio
for WuXi Biologics (Cayman) Inc.

What is the historical Revenue growth
over the last 5 years for WuXi Biologics (Cayman) Inc?

What is the historical Net Income growth
over the last 5 years for WuXi Biologics (Cayman) Inc?

What is the current Free Cash Flow
of WuXi Biologics (Cayman) Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for WuXi Biologics (Cayman) Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
WuXi Biologics (Cayman) Inc

Current Assets 19.8B
Cash & Short-Term Investments 9.5B
Receivables 6.8B
Other Current Assets 3.4B
Non-Current Assets 36.3B
Long-Term Investments 2.8B
PP&E 30.8B
Intangibles 2B
Other Non-Current Assets 700.4m
Current Liabilities 6.8B
Accounts Payable 3.1B
Accrued Liabilities 393.2m
Other Current Liabilities 3.4B
Non-Current Liabilities 8.6B
Long-Term Debt 3.5B
Other Non-Current Liabilities 5.2B
Efficiency

Earnings Waterfall
WuXi Biologics (Cayman) Inc

Revenue
17.1B CNY
Cost of Revenue
-10.5B CNY
Gross Profit
6.6B CNY
Operating Expenses
-2.8B CNY
Operating Income
3.9B CNY
Other Expenses
-1.2B CNY
Net Income
2.6B CNY

Free Cash Flow Analysis
WuXi Biologics (Cayman) Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

WuXi Biologics (Cayman) Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Operating Income
Positive Net Income
53/100
Profitability
Score

WuXi Biologics (Cayman) Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

WuXi Biologics (Cayman) Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Negative Net Debt
83/100
Solvency
Score

WuXi Biologics (Cayman) Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WuXi Biologics (Cayman) Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 21.03 HKD with a low forecast of 8.59 HKD and a high forecast of 36.75 HKD.

Lowest
Price Target
8.59 HKD
51% Downside
Average
Price Target
21.03 HKD
20% Upside
Highest
Price Target
36.75 HKD
110% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for WuXi Biologics (Cayman) Inc?

Click here to dive deeper.

Dividends

WuXi Biologics (Cayman) Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for WuXi Biologics (Cayman) Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one WuXi Biologics (Cayman) Inc stock?

The intrinsic value of one WuXi Biologics (Cayman) Inc stock under the Base Case scenario is 32.48 HKD.

Is WuXi Biologics (Cayman) Inc stock undervalued or overvalued?

Compared to the current market price of 17.46 HKD, WuXi Biologics (Cayman) Inc is Undervalued by 46%.

Back to Top